Probiotics: Clinical Trials

6 trials of Probiotics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 6
Phase 12Terminated 2
Phase 32Terminated 2

Follow Probiotics: new trials by email Literature Review of Probiotics trials Research Report on Probiotics

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
"CHANGE COVID-19 Severity"
Magnesium Citrate plus probiotic - COVID-19 Infection
Phase 1 / Phase 2TerminatedVanderbilt University Medical Center232021-11-042023-11-13
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
Align Probiotic Supplement Capsule, Placebos - Fatty Liver Disease, Fibrosis, Liver
Phase 1 / Phase 2TerminatedCorewell Health East142021-01-122022-09-27
The Effect of a Probiotic on Protection Against Upper Respiratory Tract Infections in Children
probiotic, placebo - Upper Respiratory Tract Infection
Phase 2TerminatedProbi AB1312013-08-012015-12-03
Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort
Probiotics, Control - Abdominal Discomfort
Phase 2TerminatedProbi AB52013-04-012016-09-22
Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea
Probiotic, Placebo - Antibiotic-associated Diarrhoea
Phase 2 / Phase 3TerminatedDanisco2582012-12-012016-01-22
Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia
Probiotic, Placebo - IBS-D and Functional Dyspepsia
Phase 2 / Phase 3TerminatedSprim Advanced Life Sciences1202011-01-012011-07-21

Conditions studied

COVID-19 (1)  ·  Diarrhea (1)  ·  Dyspepsia (1)  ·  Fatty Liver (1)  ·  Fibrosis (1)  ·  Liver Cirrhosis (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Respiratory Tract Infections (1)

Sponsors

Probi AB (2)  ·  Corewell Health East (1)  ·  Danisco (1)  ·  Sprim Advanced Life Sciences (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (3)  ·  Finland (1)  ·  Germany (1)  ·  Sweden (1)

Top investigators

Anneli Tarpila, PhD (1)  ·  David Wyatt, MD (1)  ·  Duane Wombolt, MD (1)  ·  Mariquit Sendelbach, DO (1)  ·  Toivo Piippo, MD (1)

Results publications

PMID 32283645